An official European Respiratory Society statement on physical activity in COPD

Henrik Watz(World Water Watch), Fábio Pitta(Universidade Estadual de Londrina), Carolyn L. Rochester(Yale University), Judith García‐Aymerich(The Task Force for Global Health), Richard ZuWallack(Saint Francis Hospital & Medical Center), Thierry Troosters(The Task Force for Global Health), Anouk W. Vaes(The Task Force for Global Health), Milo A. Puhan(University of Basel), Melissa Jehn(The Task Force for Global Health), Michael I. Polkey(The Task Force for Global Health), Ioannis Vogiatzis(The Task Force for Global Health), Enrico Clini(The Task Force for Global Health), Michael J. Toth(University of Vermont), Elena Gimeno‐Santos(The Task Force for Global Health), Benjamin Waschki(The Task Force for Global Health), Cristóbal Esteban(Hospital de Galdakao), Maurice Hayot(The Task Force for Global Health), Richard Casaburi(University of California, Los Angeles), János Pórszász(University of Illinois Urbana-Champaign), Edward McAuley(Glenfield Hospital), Sally Singh(The Task Force for Global Health), Daniël Langer(The Task Force for Global Health), Emiel F.�M. Wouters(The Task Force for Global Health), H Magnussen(The Task Force for Global Health), Martijn A. Spruit
European Respiratory Journal
October 30, 2014
Cited by 517Open Access
Full Text

Abstract

This European Respiratory Society (ERS) statement provides a comprehensive overview on physical activity in patients with chronic obstructive pulmonary disease (COPD). A multidisciplinary Task Force of experts representing the ERS Scientific Group 01.02 "Rehabilitation and Chronic Care" determined the overall scope of this statement through consensus. Focused literature reviews were conducted in key topic areas and the final content of this Statement was agreed upon by all members. The current knowledge regarding physical activity in COPD is presented, including the definition of physical activity, the consequences of physical inactivity on lung function decline and COPD incidence, physical activity assessment, prevalence of physical inactivity in COPD, clinical correlates of physical activity, effects of physical inactivity on hospitalisations and mortality, and treatment strategies to improve physical activity in patients with COPD. This Task Force identified multiple major areas of research that need to be addressed further in the coming years. These include, but are not limited to, the disease-modifying potential of increased physical activity, and to further understand how improvements in exercise capacity, dyspnoea and self-efficacy following interventions may translate into increased physical activity. The Task Force recommends that this ERS statement should be reviewed periodically (e.g. every 5-8 years).


Related Papers

No related papers found

Powered by citation graph analysis